Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis

ConclusionIn nonanaplastic meningiomas, Lutathera ®’s antitumoral activity appeared delayed and more likely observed at six months, while no major response was observed under treatment. Moreover, its antitumoral activity persisted for 12–18 months following treatment initiation.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research